Tango Therapeutics, Inc. (TNGX)
22.38
-0.46
(-2.01%)
USD |
NASDAQ |
Sep 01, 09:49
Tango Therapeutics Net Income (TTM) : -123.72M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -123.72M |
| March 31, 2026 | -107.23M |
| December 31, 2025 | -101.59M |
| September 30, 2025 | -100.52M |
| June 30, 2025 | -145.57M |
| March 31, 2025 | -132.26M |
| December 31, 2024 | -130.30M |
| September 30, 2024 | -123.40M |
| June 30, 2024 | -116.49M |
| March 31, 2024 | -111.65M |
| December 31, 2023 | -101.74M |
| Date | Value |
|---|---|
| September 30, 2023 | -100.04M |
| June 30, 2023 | -106.83M |
| March 31, 2023 | -110.98M |
| December 31, 2022 | -108.18M |
| September 30, 2022 | -101.16M |
| June 30, 2022 | -91.70M |
| March 31, 2022 | -71.34M |
| December 31, 2021 | -58.24M |
| September 30, 2021 | -45.05M |
| June 30, 2021 | -52.26M |
| March 31, 2021 | -47.77M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Revolution Medicines, Inc. | -1.768B |
| Erasca, Inc. | -287.22M |
| NovelStem International Corp. | -0.3076M |
| Brainstorm Cell Therapeutics, Inc. | -10.52M |
| Summit Therapeutics, Inc. | -856.09M |